Ajooni Biotech Rights Issue 2024 vs Markobenz Ventures Limited Rights Issue 2024

Comparison between Ajooni Biotech Rights Issue 2024 and Markobenz Ventures Limited Rights Issue 2024.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Ajooni Biotech Rights Issue 2024 and Markobenz Ventures Limited Rights Issue 2024. Ajooni Biotech Rights Issue 2024 is listed on NSE while Markobenz Ventures Limited Rights Issue 2024 is listed on BSE.

 Ajooni Biotech LimitedMarkobenz Ventures Limited
LogoAjooni Biotech Rights Issue 2024 Logo
Listing AtNSEBSE
Terms of Payment

Full amount of Rs.5.00 per Equity Share is payable on application.

The amount of Rs.10/- per Rights Equity Share to be paid on Application

Entitlement1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date3 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarCameo Corporate Services Ltd.Purva Sharegistry (India) Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Ajooni Biotech Rights Issue 2024 rights issue is ₹43.81 Crores, whereas Markobenz Ventures Limited Rights Issue 2024 rights issue size is ₹14.40 Crores.

 Ajooni Biotech LimitedMarkobenz Ventures Limited
Issue Size8,76,13,721 shares1,44,00,000 shares
Issue Size (Amount)₹43.81 Crores₹14.40 Crores
Issue Price₹5 per share₹10 per share
Face Value₹2 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Ajooni Biotech Rights Issue 2024 is May 07, 2024 while record date of Markobenz Ventures Limited Rights Issue 2024 is Mar 27, 2024.

 Ajooni Biotech LimitedMarkobenz Ventures Limited
Record DateMay 07, 2024Mar 27, 2024
Credit of Rights EntitlementsApr 18, 2024
Bid/Offer Opens OnMay 21, 2024Apr 15, 2024
Renunciation of Rights EntitlementsMay 27, 2024Apr 16, 2024
Bid/Offer Closes OnMay 31, 2024Apr 30, 2024
Deemed Date of AllotmentJun 06, 2024
Credit DateJun 11, 2024
Listing DateJun 14, 2024

Financials details

Comparison of Ajooni Biotech Rights Issue 2024 and Markobenz Ventures Limited Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Ajooni Biotech LimitedMarkobenz Ventures Limited
Financial

Ajooni Biotech Limited Financial Information (Restated)

Ajooni Biotech Limited's revenue increased by 0.95% and profit after tax (PAT) rose by 7.23% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets58.7329.0228.03
Revenue74.7874.08
Profit After Tax1.121.050.37
Net Worth43.9918.5141.9417.46
Reserves and Surplus26.47
Total Borrowing3.095.185.356.78
Amount in ₹ Crore

Markobenz Ventures Limited Financial Information (Restated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets0.020.020.02
Profit After Tax-0.17-0.11-0.14
Net Worth-7.21-7.04
Amount in ₹ Crore

Compare with others

Compare:

Ajooni Biotech Rights Issue 2024 Vs Markobenz Ventures Limited Rights Issue 2024